Rumors had been circulating for months, and for several weeks now, insiders had been talking about it more and more frequently, but there had never been an official announcement or confirmation. Even we, the Italian front store of Farmacia Italiana Genova, knew something, but we never received an official communication... now it's official: Farmacia Italiana Genova, the Italian leader in the testing and production of sports medicines and P.E.Ds, has acquired a majority stake in the group. Kuwait Pharma Labs, the large UGL laboratory in the Middle East.
The story of the negotiations between Kuwait Pharma and Farmacia Italiana Genova
For years, Kuwait Pharma Labs has been at the forefront of the industry thanks to its connections with Oxygen Gym and its professional sports team in Kuwait, which has produced great bodybuilding champions such as Roelly Winklaar and Mr. Olympia 2019 Brandon Curry, among others, and launched immense talents such as the current two-time Mr. Olympia Big Ramy. For years, there has been speculation about how these talents exploded and became unbeatable champions, transforming Kuwait into a veritable bodybuilding mecca. At that time, when the possession of anabolic steroids was legal in Kuwait, Kuwait Pharma Labs was the number one supplier and one of the main producers of steroids for Kuwait and its sports teams.
In 2020, just before the pandemic, Kuwait significantly tightened its laws against the proliferation of PEDs and anabolic steroids, forcing Kuwait Pharma to change markets and focus more on Europe. Farmacia Italiana Genova, thanks to its network of sports teams around the world, was the first official distributor of Kuwait Pharma products in Europe, and we at Steroidi Anabolizzanti Italia were the first to distribute them in Italy, with great success and appreciation from our customers.
Unfortunately for KP, the European market is not as straightforward as the Middle Eastern market (especially if you are not based in the EU), and direct sales by Kuwait Pharma through their website and sales representatives were not high enough to justify such a large laboratory with several professional employees. Therefore, the only solution was to close or sell the business (at least the European part). After lengthy negotiations lasting almost a year, it is now official that Farmacia Italiana Genova has acquired more than 80% of Kuwait Pharma Labs, including laboratory equipment, staff, warehouse, and the entire catalog.
What happens now?
The transition will not be immediate: Kuwait Pharma will continue to operate, at least for now, under the Kuwait Pharma Labs brand, even though it will be part of the Farmacia Italiana Genova group (with its tax domicile in the Netherlands and laboratories in Italy), as will be highlighted in the future on labels and merchandising. The first official step is expected at the end of October, when those who buy on the kuwaitpharma.com website will in fact already be paying directly to Farmacia Italiana. The KP website has already announced the change of ownership.
For you, our customers, the difference will be minimal, as little or nothing will change except that the quality of the Kuwait Pharma brand will improve thanks to the know-how of Farmacia Italiana Genova.
Stay tuned for further updates.
